Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro.
about
Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.The Structural Basis for the Integrity of Adenovirus Ad3 DodecahedronBUD22 affects Ty1 retrotransposition and ribosome biogenesis in Saccharomyces cerevisiaeAdenovirus dodecahedron, as a drug delivery vectorCapsomer vaccines protect mice from vaginal challenge with human papillomavirusSerological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia.Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model.Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines.In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids.Characterization of a major neutralizing epitope on human papillomavirus type 16 L1L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidationProduction of infectious human papillomavirus independently of viral replication and epithelial cell differentiation.Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy.Diffusion of macromolecules and virus-like particles in human cervical mucusEnhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirusDisassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay.Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.Underlying assumptions of developmental models.A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome PackagingPossible role for cellular karyopherins in regulating polyomavirus and papillomavirus capsid assembly.Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops.Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeresExpression and characterization of HPV-16 L1 capsid protein in Pichia pastoris.Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines.Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform.Chaperone-mediated in vitro disassembly of polyoma- and papillomaviruses.Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity.
P2860
Q27472900-638D1760-B18C-4C7D-8093-A4A83A64841CQ27674368-073AF770-EFF2-40A5-A313-836279ED2DC2Q27933691-BBBE8756-7673-479C-A4D3-E66168E04EE4Q28475489-24194D7A-DC9C-4A55-896E-E8AB8C1008B4Q28743261-D33D854E-5731-4ACF-B42E-79B8FCFA7547Q33620823-FAA69DE0-3FD1-4EE4-AD54-BE5D4DA7E450Q33728320-5157F13A-2F4B-40D2-BE5B-1BA0F9CD30F1Q33785841-1C16706C-630A-4CF6-BBAA-063D6F35599FQ33785870-6823A3CB-1452-436A-9319-605FB4A25564Q33786402-C1C85268-2F00-485C-8224-53B81FC4C975Q33813986-C80DC395-8793-490D-9F03-783037E58E60Q33839721-103A39D2-8349-4916-8481-D5EAD7DEA8CFQ33879132-5BD7B0E8-C2F7-4038-A304-B48844400689Q34033805-E5C15602-85AF-40BB-A905-472EC249CE4AQ34176484-513E9118-9A39-476F-8BAA-60B902783BADQ34203433-77B2AF2F-950F-494C-B853-54C81A4ADFA9Q34256293-DC652E45-AC54-475A-8DA2-F0B7610D46AAQ34315981-E84E5E27-5C41-42CD-8868-532D10699CDBQ34579346-2E6CFD44-8669-4530-900A-8FC51CA886F9Q34617331-C0A4477D-0FF5-4C67-AEDC-B9398D42CA2BQ35165017-D890BC94-F00E-4FBE-92B5-69E49C7C50F4Q36258831-04AF9545-76B7-49BA-9E06-E1B83030563DQ36434185-EFDBA108-2D78-49D6-84BA-8A8996D434DAQ36933885-1EF126BA-701F-4E3F-8338-878E5795105CQ37226543-E50B04B4-E459-486F-8824-65ABBD36EA17Q37242405-02F60F2B-C36C-4E8C-B8C1-2AF4698A9A94Q37280045-E2A941F2-4BF0-4E1F-BA27-1A6B02709041Q37356046-9DFDCB40-F2BF-44AD-90B9-D07CC6FC60EFQ39742082-FAFA48C1-2C55-4524-B943-BAE4DD6FEF51Q40382460-C36DBD00-0AEA-4477-9E98-5EA4EED0DEDFQ42072226-91AA6536-590A-47AC-8878-7EF7C5434007Q43096878-99EC75F4-34FC-4774-855D-3EF92187ECA2
P2860
Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Quantitative disassembly and r ...... viruslike particles in vitro.
@en
Quantitative disassembly and r ...... viruslike particles in vitro.
@nl
type
label
Quantitative disassembly and r ...... viruslike particles in vitro.
@en
Quantitative disassembly and r ...... viruslike particles in vitro.
@nl
prefLabel
Quantitative disassembly and r ...... viruslike particles in vitro.
@en
Quantitative disassembly and r ...... viruslike particles in vitro.
@nl
P2093
P2860
P1433
P1476
Quantitative disassembly and r ...... 1 viruslike particles in vitro
@en
P2093
F Palmer-Hill
J A Suzich
M P McCarthy
P2860
P407
P577
1998-01-01T00:00:00Z